tbuckley/cabot-search huggingface dataset:
Glofitamab in Combination with Polatuzumab Vedotin Maintains Durable Responses and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Including High-Grade B-Cell Lymphoma (HGBCL): Extended Follow-up of a Phase Ib/II Study
Authors: Martin Hutchings, Anna Sureda Balari, Francesc Bosch, Thomas Stauffer Larsen, Paolo Corradini, Abraham Avigdor, María José Terol, Antonio Rueda Dominguez, Antonio Pinto, Alan P Skarbnik, Raul Cordoba, Judit Mészáros Joergensen, Pier Luigi Zinzani, Ronit Gurion, Neta Goldschmidt, Wilfred Leung, Donghang Li, James Relf, Maneesh Tandon, Gila Sellam, Giuseppe Gritti
Journal: Blood (2024)
Treatment of Idiopathic Aplastic Anemia (AA) with Expanded Autologous Regulatory T Cells: The Tiara Phase One Trial
Authors: Nazia Matto, Shreyans Gandhi, Marta Rzepkowska, Sila Gerlevik, Mohammad M Karimi, Austin G. Kulasekararaj, Abdel Douiri, Angela Miller, Lynne Duran, Haili Cui, Jen Lewis, Shahram Kordasti, Giovanna Lombardi, Giorgio Napolitani, Ghulam Jeelani Mufti
Journal: Blood (2024)
Serine Threonine Protein Kinase 25 (STK25) Is a New Mediator of Myelopoiesis and Myeloid Cell Effector Function(s) during Injury and Inflammation
Authors: Matthew R Rice, Bharati Matta, Leianna Brune, Julia E Froese, Hazel F Wright, Amanda F Beneat, Vaishali J Jha, Lionel Blanc, Betsy J. Barnes
Journal: Blood (2024)
IL-33+ Stromal Cells in the Lymphoid Tissues Program Donor CD4+ T Cell Exhaustion That Blunts Subsequent IL-33+ Target Tissue-Driven Pathology but Not Graft Vs. Lymphoma Responses
Authors: Gaelen Dwyer, Lisa Mathews, Bailey Chalmers, Afsana Naaz, Amanda Poholek, Craig Byersdorfer, Faruk Sacirbegovic, Warren Shlomchik, Heth Turnquist
Journal: Blood (2024)
Structural and Functional Analysis of the Clonotypic B Cell Receptor Immunoglobulin in Splenic Marginal Zone Lymphoma: Ontogenetic and Therapeutic Implications
Authors: Anastasia Iatrou, Marco Patrone, Ioannis Sarrigeorgiou, Nikolaos Pechlivanis, David Graham Oscier, Alexandra Traverse-Glehen, Raphael Sandaltzopoulos, Niki Stavroyianni, Andreas Agathangelidis, Georgios Petrakis, Triantafyllia Koletsa, Peggy Lymberi, Paolo Ghia, Anastasia Chatzidimitriou, Massimo Degano, Kostas Stamatopoulos
Journal: Blood (2024)
A Phase I Study of a Novel BCMA×CD3 Bispecific Antibody Emb-06 in Relapsed or Refractory Multiple Myeloma
Authors: Peter Tan, LI Bao, Qingsong Yin, Chunrui Li, Sorab Jehangir Shavaksha, H. Miles Prince, Zhen Cai, SHAN GAO, Qian Wang, Di Wang, YI LI, Mingfei Zhang, Qiumei Deng, Qiaoyang Lu, Chengjun Jiang, Fang Ren, Danqing Wu, Shuqi Zeng, Yonghong Zhu, Yi Tao, Yuanfang Liu, Jian-Qing Mi
Journal: Blood (2024)
CTLA-4-Based Activation Inducible Costimulatory Receptors Endow CAR-T Cells with Safe, Tumor-Restricted, Multi-Targeting and Increased Persistence
Authors: Afroditi Katsarou, Georgios Kladis, Alexandros Nianias, Jiaxian Wang, Thomas Baardemans, Ruud Ruiter, Marie José Kersten, Sonja Zweegman, Tuna Mutis, Richard Groen, Maria Themeli
Journal: Blood (2024)
Longitudinal Contribution of Distinct Hematopoietic Clones during Marrow Recovery in Immune Aplastic Anemia
Authors: Fernanda Gutierrez-Rodrigues, Emma M. Groarke, Lemlem Alemu, Olga Rios, Diego Quinones Raffo, Jennifer Lotter, Neal S. Young, Bhavisha A. Patel
Journal: Blood (2024)
Efficacy and Safety of Pozelimab Plus Cemdisiran Vs Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Are Naïve to Complement Inhibition
Authors: Christopher Patriquin, Jun-Ho Jang, Lisa Aurand, Deepak Taneja, Andrew Magyar, Bradley Dain, Karoline Meagher, Lorah Perlee, Amal Souttou, Morag Griffin
Journal: Blood (2024)
Primary Analysis of ZUMA-2 Cohort 3: Brexucabtagene Autoleucel (Brexu-Cel) in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Who Were Naive to Bruton Tyrosine Kinase Inhibitors (BTKi)
Authors: Tom van Meerten, M.J. Kersten, Gloria Iacoboni, Georg Hess, Pim Mutsaers, Alejandro Martín García-Sancho, Andre Goy, Eva Gine, Brian T. Hill, Wen-Kai Weng, Martin Dreyling, Patrick M. Reagan, Krish Patel, Ahmed Galal, Charles Herbaux, Robin Sanderson, Dan Zheng, Justyna Kanska, Wangshu Zhang, Rita Damico Khalid, Ioana Kloos, Michael Wang
Journal: Blood (2024)
Prognostic Understanding for Older, Medically Infirm, and/or Frail Recipients of Allogeneic Hematopoietic Cell Transplantation in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)
Authors: Elizabeth T. Loggers, James Fausto, Matthew Givens, Mei-Ean Yeow, Reena V. Jayani, Hassan B Alkhateeb, Laura A Schoenherr, Michael W. Rabow, Mark B Juckett, George Carrum, Joseph Uberti, Kyle Neale, Santiago Lopez, Diana Martins-Welch, Jeanette G Ferrer, Laura S Rhee, Drew A Rosielle, Susan McInnes, Jason A Webb, Rachel J. Cook, Elisheva Newman, Ronald Sobecks, Laura Johnston, Mohamed Sorror
Journal: Blood (2024)
Generation of Functional iPSC-Derived CAR-T Cells for Cancer Immunotherapy Via G9a/GLP Inhibition
Authors: Ran Jing, Marcelo Falchetti, Tianxiao Han, Mohamad Najia, Luca Hensch, Eleanor Meader, Martin Kononov, Stephanie Wang, Caroline Kubaczka, Edroaldo Lummertz Da Rocha, Robert Grant Rowe, Thorsten M. Schlaeger, Marcela Maus, Trista E. North, Leonard I. Zon, George Q. Daley
Journal: Blood (2024)
Association of Clonal Hematopoiesis of Indeterminate Potential (CHIP) with Incidence of Venous Thromboembolism Varies By Age: The Atherosclerosis Risk in Communities Study
Authors: Seyedmohammad Saadatagah, Rockbum Kim, Senthil Sukumar, Md Mesbah Uddin, Aaron R. Folsom, Mary Cushman, Weihong Tang, Pradeep Natarajan, Christie M. Ballantyne, Pamela Lutsey, Ang Li
Journal: Blood (2024)
Empowering Adolescents and Young Adults with Sickle Cell Disease: Development of a Shared Decision-Making Toolkit for Disease-Modifying Therapies
Authors: Aimee K. Hildenbrand, Melanie L Pitone, Benjamin Bear, Alyssa Decino, Corinna L. Schultz, Melissa A. Alderfer, Lori E. Crosby
Journal: Blood (2024)
Immune Mechanisms and Cytokine Profiles in Hemophilia a Patients Undergoing Low-Dose ITI and Emicizumab Prophylaxis: Implications for ITI Success and Failure
Authors: Jessica O. Frade-Guanaes, Carolina Costa-Lima, Vanessa B. Faiotto, Ana P. Francisco, Nívia M. Foschi, Andrea L. A. Sambo, Mariana M. T. Hosokawa, Valdirene Stahl, Luiz G. R. Lima, Bianca Stefanello, Lucas W. Weiss Santos, Samuel S. Medina, Marina P. Colella, Silmara A. De Lima Montalvão, Gabriela G. Yamaguti-Hayakawa, Margareth C. Ozelo
Journal: Blood (2024)
Biological and Clinical Significance of Endogenous and Chimeric Antigen Receptor (CAR) T Cell Immune Profiling in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Authors: Bruno Paiva, Irene Manrique, Ethan G. Thompson, Timothy B. Campbell, Camila Guerrero, Nathan Martin, Larry D Anderson, Jesus G Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, Philippe Moreau, Jesús F. San-Miguel, Nikhil C. Munshi, Shari Kaiser
Journal: Blood (2024)
Ibrutinib-Rituximab Is Superior to Rituximab-Chemotherapy in Previously Untreated Older Mantle Cell Lymphoma Patients: Results from the International Randomised Controlled Trial, Enrich
Authors: David John Lewis, Mats Jerkeman, Lexy Sorrell, David Wright, Ingrid Glimelius, Annika Pasanen, Jacob Haaber Christensen, Karin Fahl Wader, Andrew J. Davies, Nick Morley, Christopher McNamara, Christian Bjørn Poulsen, Jon Riise, Kristina Sonnevi, Ingemar Lagerlöf, Cathy Burton, Surita Dalal, Andrew Rawstron, Ruth M de Tute, Victoria Allgar, Sree Aroori, Mark Warner, Brian Wainman, Claire Scully, Jeanette Sanders, Carsten Utoft Niemann, Helle Toldbod, Nicola Crosbie, Mark J Bishton, Toby A. Eyre, Simon Rule
Journal: Blood (2024)
Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with <i>KMT2Ar</i> or <i>NPM1</i> Alterations
Authors: Christian Recher, Jenny O'Nions, Ibrahim Aldoss, Ana Alfonso Pierola, Alicia Allred, Juan Manuel Alonso-Dominguez, Laura Barreyro, Pierre Bories, Martin Curtis, Nikki Daskalakis, Matteo Giovanni Della Porta, Hartmut Döhner, Amber D'Souza, James P. Dugan, Jordi Esteve Reyner, Matthew Exum, Amir T. Fathi, Pasquale L. Fedele, Lucille Ferrante, Stan Gaj, Sylvain Garciaz, Ana Garrido, Sara Garrido Paniagua, Christina Guttke, Emmanuel Gyan, Brett Hiebert, Elias Jabbour, Madlen Jentzsch, Hagop M. Kantarjian, Marina Konopleva, Jan Krönke, Min Chul Kwon, Christina Loefgren, Oliver Lomas, Valentina Mancini, Ioannis Mantzaris, Giovanni Martinelli, Daniel Morillo Giles, Joseph Murphy, Kathryn Packman, Cristina Papayannidis, Ulrike Philippar, Uwe Platzbecker, Sravanti Rangaraju, Christoph Röllig, Olga Salamero, Madhu Sanga, Tim Sauer, Emma Searle, Natalia Tovar, Trevor Tucker, Nicolas Vallet, Lachlin Vaughan, Gala Vega, Paresh Vyas, Andrew Wei
Journal: Blood (2024)
A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells
Authors: Ran Kong, Shi Feng, Cong Wang, Qingbo Hao, Yu Zhang, Jingjing Han, Xiaoyu Xie, Haiyang Wang, Jan Elsner, Derek Mendy, Michael Haughey, Paul Krenitsky, Veronique Plantevin-Krenitsky, Patrick Papa, Frank Mercurio, Weilin Xie, Xiangxiang Zhou
Journal: Blood (2024)
Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises
Authors: Ashish O. Gupta, Akshay Sharma, Haydar Frangoul, Jignesh Dalal, Julie Kanter, Asif Alavi, John DiPersio, Mary Eapen, Jennifer J. Jaroscak, Ernesto Ayala, Edward D. Ziga, Stacey Rifkin-Zenenberg, Alex C. Minella, Guo Chen, Yinzhong Chen, Priya S. Chockalingam, Ling Lin, Marcelyne Joseney-Antoine, Leanne Ianniello, Beth Gardner, Adam J. Hartigan, Giuseppe Ciaramella, Sunita Goyal, Amy Simon, Alexis Thompson, Matthew M. Heeney
Journal: Blood (2024)
Impact of Total Body Irradiation-Based Conditioning Regimens on Outcomes in Patients with Aggressive Mature T-Cell Lymphomas Undergoing Allogeneic Hematopoietic Cell Transplant
Authors: Yenny Alejandra Moreno Vanegas, Urshila Durani, Christine Goth, Nandita Khera, Zhuo Li, Hemant S. Murthy, Vivek Roy, James M. Foran, Ernesto Ayala, Mohamed A. Kharfan-Dabaja, Jasmine Zain, Madiha Iqbal
Journal: Blood (2024)
Armored Multivalent CAR-T Cells Targeting BCMA, GPRC5D, and CD38 Eradicate Antigen-Heterogeneous Multiple Myeloma, Address Antigen Escape and Enhance Expansion
Authors: Jincai Zhou, Xinran Luo, Bixia Lei, Kai Wu, Feifei Shi, Yuting Zhang, Jingyi Yu, Hong Ma, Zhe (Joy) Zhou, Xiaowen He
Journal: Blood (2024)
Interim Analysis Data from Multi-Center Retrospective Observational Study of Effectiveness, Safety, and Treatment Status of Tirabrutinib in 161 Japanese Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma: Rosetta Study
Authors: Motoo Nagane, Manabu Natsumeda, Fumiharu Ohka, Fumiyuki Yamasaki, Hajime Yonezawa, Nobuyoshi Sasaki, Shigeru Yamaguchi, Kensuke Tateishi, Yoshitaka Narita, Yasukazu Kawai, Hiroyuki Sugahara, Jyunichiro Kuroda, Takeshi Okuda, Tomoo Matsutani, Manabu Kinoshita, Naoto Tomita, Keiichiro Hattori, Jun Muto, Noriaki Kitamura, Keita Kinoshita, Kazuhiko Mishima
Journal: Blood (2024)
Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Degrader NX-5948 in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Updated Results from an Ongoing Phase 1a/b Study
Authors: Nirav N. Shah, Zulfa Omer, Graham P. Collins, Francesco Forconi, Alexey Danilov, John C. Byrd, Dima El-Sharkawi, Emma Searle, Alvaro J Alencar, Shuo Ma, Sarah Injac, Talha Munir
Journal: Blood (2024)
Identification of Risk Factors for Myeloma Progression in African American Patients
Authors: David E. Mery, Yihao Zhan, Hongling Peng, Eric Siegel, Cody Ashby, Clyde Bailey, Catherine Ma, Hongwei Xu, Samer Al Hadidi, Carolina Schinke, Maurizio Zangari, Sharmilan Thanendrarajan, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan
Journal: Blood (2024)
Utility of the Central Nervous System International Prognostic Index (CNS-IPI) in Patients with Primary Mediastinal B-Cell Lymphoma Treated with Rituximab-Containing Chemoimmunotherapy
Authors: Jiayu Yang, Anna R. Hayden, Diego Villa, Aixiang Jiang, Alina S. Gerrie, Christopher P. Venner, Pedro Farinha, David W. Scott, Laurie H. Sehn, Kerry J. Savage
Journal: Blood (2024)
Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1
Authors: Alexey Danilov, Bita Fakhri, Farrukh T. Awan, Hans Herluf Bentzen, Herbert A. Eradat, Carsten Utoft Niemann, Fritz Offner, Christian Bjørn Poulsen, Thor Hoeyer, Mar Bellido, Damien Roos Weil, Alessandra Ferrajoli, Meghan C. Thompson, Jacob Haaber Christensen, Ann Janssens, Tamar Tadmor, Mazyar Shadman, Pegah Jafarinasabian, Jimin Zhang, Marcia Rios, Alexandra Kuznetsova, Rebecca Valentin, Arnon P. Kater
Journal: Blood (2024)
Omission of Bleomycin in Limited Stage Classic Hodgkin Lymphoma Patients with a Negative PET Scan Following 2 Cycles of ABVD Is Associated with Comparable Outcomes and Reduced Pulmonary Toxicity
Authors: Jiayu Yang, Diego Villa, Alina S. Gerrie, Petter Tonseth, Don C. Wilson, Francois Benard, Graham W. Slack, Christopher P. Venner, Andrea C. Lo, David W. Scott, Laurie H. Sehn, Kerry J. Savage
Journal: Blood (2024)
Intrinsic Tumor Drivers and Immune Escape Mechanisms in CD19 CAR T-Cell Therapy Resistance for Aggressive Large B Cell Lymphoma
Authors: Bachisio Ziccheddu, Michael D. Jain, Monika Chojnacka, Michael Durante, Venu Venkatarame Gowda Saralamma, Austin Daniel Newsam, Jerald Noble, Nicholas B Figura, Meghan Menges, Ola Landgren, Marco Davila, Jonathan H. Schatz, Francesco Maura, Frederick L. Locke
Journal: Blood (2024)
Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial
Authors: Daniel J. DeAngelo, Jun Yin, Anjali S. Advani, Selina Luger, Jill Fulcher, Michaela Liedtke, Geoffrey L. Uy, Shira N. Dinner, Lindsay Wilde, Marlise R. Luskin, Caner Saygin, Ella Postich, Noreen Fulton, Richard C. Harvey, Gaby E Perez Burbano, Rebecca Teske, Harry P. Erba, Mark R. Litzow, Richard M. Stone, Wendy Stock
Journal: Blood (2024)
Waveline-007: Dose Escalation and Confirmation, and Efficacy Expansion Trial of Zilovertamab Vedotin in Combination with Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab in Patients with Diffuse Large B Cell Lymphoma
Authors: Muhit Ozcan, Eva Gonzalez Barca, Tae Min Kim, Ewa Paszkiewicz-Kozik, Jan M. Zaucha, Stefan Hohaus, Marco Ladetto, Caterina Patti, Sebastian Giebel, Tadeusz Robak, Ömür Gökmen Sevindik, Yulia Volchek, Benedetta Puccini, Guillermo Rodríguez Garcia, Raul Cordoba, Okan Seyran, Siruo Wang, L. Puja Patel, Rushdia Yusuf, David Lavie
Journal: Blood (2024)
Tocilizumab Prophylaxis for Patients with Relapsed or Refractory Multiple Myeloma Treated with Teclistamab, Elranatamab or Talquetamab
Authors: Andrew Kowalski, Jill Lykon, Benjamin Diamond, David G. Coffey, Marcella Kaddoura, Francesco Maura, James E. Hoffman, Dickran Kazandjian, Ola Landgren
Journal: Blood (2024)
Integrative Multi-Omics Analyses Identify a High-Risk Subgroup of Patients with Poor Prognosis in t(8;21) Acute Myeloid Leukemia
Authors: Yu Liu, Wenbing Liu, Yihan Mei, Qing Rao, Runxia Gu, Min Wang, Jianxiang Wang, Shaowei Qiu
Journal: Blood (2024)
pkm2 Binds to the Regulatory Regions of Gata-1 and stat5 in β-Thalassemic Mouse Erythroblasts
Authors: Enrica Federti, Silvia Pietrobono, Veronica Riccardi, Jacopo Ceolan, Richard Pozzetto Huot, Filippo Mazzi, Tolunay Kavaz, Immacolata Andolfo, Roberta Russo, Davide Melisi, Achille Iolascon, Lucia De Franceschi
Journal: Blood (2024)
Development of a ZBTB7A and Wiz Dual Degrading, HbF-Activating CELMoD™ for the Treatment of Sickle Cell Disease
Authors: Emily Rychak, Goldie Yuan Lam Lui, Cristhian Fimbres, Christine Kim Kang, Younguk Sun, Sophie Peng, Jingjing Deng, Sarah Franc, Eugene Ciccimaro, Kimberly Peacock, Minerva Tran, Andy Christoforou, Jinyi Zhu, Geraldine Polido, Barbra Pagarigan, Scott Johnson, Faye Wang, Paula Katavolos, Bonny Gaffney, Estela Garcia, France Landry, Fletcher Paddison, Petia Shipkova, Hannah Powers, Giorgio Tamò, August Dietrich, Soraya Carrancio, Radha Ramakrishnan, Karen Augustine, Rama Krishna Narla, Thomas Cummins, Mark Rolfe, Neil Bence, Antonia Lopez-Girona
Journal: Blood (2024)
CD127-Directed Immunotherapy with Lusvertikimab Outperforms Imatinib in Preclinical ABL-Class-Fusion-Positive BCP-ALL
Authors: Anna Dietterle, Julia Heymann, Anna Laqua, Claas Reimer, Denny Takudzwa Mahachi, Carina Lynn Gehlert, Dorothee Winterberg, Maja Kowol, Alexander Arthur Wurm, Philipp Fanter, Denis Pinkle, Dennis Das Gupta, Christian Vokuhl, Jan Philipp Schmid, Matthias Peipp, Martin Schrappe, Irène Baccelli, Nicolas Poirier, Monika Brüggemann, Gunnar Cario, Denis Martin Schewe, Lennart Lenk
Journal: Blood (2024)
Increased Inflammatory Cytokines in Plasma Are Associated with Sustained Treatment-Free Remission in Chronic Myeloid Leukaemia
Authors: Chung Hoow Kok, Verity A Saunders, Naranie Shanmuganathan, Liu Liu, Yazad Daruis Irani, Jade Clarson, Phuong Dang, David T Yeung, Agnes S. M. Yong, Susan Branford, Javier Pinilla-Ibarz, Richard A. Larson, Jorge E. Cortes, Michael J. Mauro, James E Thompson, Neil P. Shah, Martha Wadleigh, Ehab L. Atallah, Jerald P. Radich, Timothy P Hughes, David M Ross
Journal: Blood (2024)
W-NK1 Choreographs Innate and Adaptive Immune Responses to Provide a Robust and Durable Anti-AML Response
Authors: Tom Leedom, Basia Muz, Kristann Magee, Jayakumar Vadakekolathu, Laura Arthur, Melissa Tran, Lena Luukkonen, Nitin Mahajan, Alexander Hamil, John Muth, Melissa M Berrien-Elliott, Todd A Fehniger, Sergio Rutella, Jan K Davidson-Moncada
Journal: Blood (2024)
Mis-Splicing Derived Neoantigens and Cognate T Cell Receptors in Splicing Factor Mutant Myeloid Neoplasms
Authors: Won Jun Kim, Edie I. Crosse, Emma De Neef, Inaki Etxeberria, Erich Sabio, Eric Wang, Jan Philipp Bewersdorf, Sydney X. Lu, Andrea Belleville, Nina Fox, Cynthia Castro, Pu Zhang, Takeshi Fujino, Jennifer Lewis, Jahan Rahman, Beatrice Zhang, Jacob H. Winick, Alexander M. Lewis, Robert Stanley, Susan Dewolf, Brigita Meskauskaite Urben, Meril Takizawa, Tobias Krause, Henrik Molina, Ronan Chaligne, Priya Koppikar, Jeffrey J. Molldrem, Mathieu Gigoux, Taha Merghoub, Anthony F. Daniyan, Benjamin D. Greenbaum, Christopher A. Klebanoff, Robert K. Bradley, Omar Abdel-Wahab
Journal: Blood (2024)
Five-Year Analysis of the POLARIX Study: Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes
Authors: Gilles Salles, Franck Morschhauser, Laurie H. Sehn, Alex F. Herrera, Jonathan W. Friedberg, Marek Trněný, Georg Lenz, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew Matasar, Graham P. Collins, Yuqin Song, Antonio Pinto, Shinya Rai, Koji Izutsu, Calvin Lee, Saibah Chohan, Matthew Sugidono, Yanwen Jiang, Connie Lee Batlevi, Mark Yan, Jamie Hirata, Hervé Tilly, Christopher R. Flowers
Journal: Blood (2024)
Role of Stem-like Cells in Chemotherapy Resistance and Relapse in Pediatric T Cell Acute Lymphoblastic Leukemia (T-ALL)
Authors: Julia Costea, Kerstin K. Rauwolf, Pietro Zafferani, Tobias Rausch, Anna Mathioudaki, Judith Zaugg, Martin Schrappe, Cornelia Eckert, Gabriele Escherich, Jean-Pierre Bourquin, Beat Bornhauser, Andreas E. Kulozik, Jan O. Korbel
Journal: Blood (2024)
Combined Pirtobrutinib, Venetoclax, and Obinutuzumab As First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
Authors: Nitin Jain, Alessandra Ferrajoli, Mahesh Swaminathan, Patrick K. Reville, Jan A. Burger, Vanthana Bharathi, Himachandana Atluri, Hua-Jay J Cherng, Alex Bataller, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Koichi Takahashi, Kelly S. Chien, Musa Yilmaz, Naveen Pemmaraju, Naval Daver, Fadi G. Haddad, Yesid Alvarado Valero, Jo Ishizawa, Guillermo Montalban-Bravo, Naveen Garg, Hyunsoo Hwang, Wei Qiao, Cameron Garcia, Anna Evangelio, Ana Ayala, Deepa Sampath, Varsha Gandhi, Michael J. Keating, Hagop M. Kantarjian, William G. Wierda
Journal: Blood (2024)
CRISPR/<i>Rfx</i>Cas13d Screening Identifies the Long Non-Coding RNA (LncRNA) <i>Nfyc-AS1</i> As a Molecular Vulnerability in Acute Myeloid Leukemia (AML)
Authors: Dimitrios Papaioannou, Giovanni Gambi, Palaniraja Thandapani, Deedra Nicolet, Ziyan Lin, Krzysztof Mrózek, Olha Ivashkiv, Maria Sirenko, Bettina Nadorp, Ann-Kathrin Eisfeld, Aristotelis Tsirigos, Iannis Aifantis
Journal: Blood (2024)
COVID-19 Humoral Immunity Improves with Third and Subsequent Vaccine Doses in Patients with Plasma Cell Dyscrasias, Particularly in Those Receiving antiCD38 Therapy
Authors: Sita D. Bhella, Allison M. Wilkin, Katrina Hueniken, Abi Vijenthira, Michael Sebag, Peng Wang, Lisa K Hicks, Annette E. Hay, Arleigh McCurdy, Seyed Hosseini-Moghaddam, Donna Reece, Sarit E. Assouline, Graeme Andrew McCrae Fraser, Amaris K Balitsky, Joy Mangel, Carolyn Owen, Anthony Reiman, Laurie H. Sehn, Heather J. Sutherland, Corey Arnold, Tamara Leite, Erinn McCarthy, Curtis Cooper, Marc-Andre Langlois, C. Arianne Buchan
Journal: Blood (2024)
Common Lymphoid Progenitors and B Cell Subpopulations in the Bone Marrow Are Predictive of Treatment-Free Remission in Chronic Myeloid Leukemia
Authors: Shaun D. Patterson, Isla Nosratzadeh, Robin Young, Alan Hair, Jennifer Cassels, Richard E. Clark, Heather G Jørgensen, Helen Wheadon, Mhairi Copland
Journal: Blood (2024)
Curing CLL: Long-Term Outcomes of Chronic Lymphocytic Leukemia Patients with at Least One Year of Response to CART-19 Therapy
Authors: Benjamin F. Frost, Noelle Frey, Elizabeth O. Hexner, Stephen J. Schuster, Sunita D. Nasta, Alison W Loren, Jakub Svoboda, Daniel J. Landsburg, Bruce Levine, Joseph A. Fraietta, J. Joseph Melenhorst, Elizabeth Veloso, Wei-Ting Hwang, Carl H. June, David L. Porter, Saar Gill
Journal: Blood (2024)
Hetrombopag Added to Immunosuppressive Therapy in First-Line Treatment of Severe Aplastic Anemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Authors: Fengkui Zhang, Xin Zhao, Hong Chang, Bing Han, Sujun Gao, Miao Miao, Jianda Hu, Yanjuan Lin, Xinjian Liu, Lina Zhang, Chenghao Jin, Yingmei Li, Shengyun Lin, Jinsong Jia, Yi Wang, Chunkang Chang, Zheng Ge, Guangsheng He, Ruixiang Xia, Xiangjun Fu, Yuhua Li, Hong Liu, Kai Sun, Shunqing Wang, Linghui Xia, Weihua Zhang, Runzi Li, Junye Xiong, Wanyi Zhai
Journal: Blood (2024)
Updated Analysis of Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Nonbulky, Early-Stage Classical Hodgkin Lymphoma
Authors: Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Eva Domingo Domenech, Brian Hess, Steven Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Harsh R. Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Griffith Davis, Linda Ho, Christopher Yasenchak, Hun Ju Lee
Journal: Blood (2024)
Single-Cell Whole-Genome Sequencing of Circulating Tumor Cells in Relapsed/Refractory Multiple Myeloma Patients Receiving BCMA- or GPRC5D-Targeted Immunotherapies
Authors: Rosa Toenges, Jean-Baptiste Alberge, Francesco Corrado, Nayda Bidikian, David M. Cordas Dos Santos, Ankit K. Dutta, Elizabeth D. Lightbody, Romanos Sklavenitis Pistofidis, Adam S. Sperling, Kenneth C. Anderson, Shonali Midha, Yuxin Liu, Jacob P. Laubach, Eric L. Smith, Nikhil C. Munshi, Omar Nadeem, Irene Ghobrial, Gad Getz
Journal: Blood (2024)
Dual-Vector-Transduction with Single-Step Magnetic Selection (Zip-sort) Increases Transgenic Payloads to Enhance CAR T Cell Activity
Authors: Scott E. James, Sophia Chen, Brandon Ng, Jacob Fischman, Lorenz Jahn, Alexander P. Boardman, Adhithi Rajagopalan, Harold K Elias, Alyssa R Massa, Dylan Manuele, Katherine Nichols, Amina Lazrak, Nicole Lee, Aoife Doto, Alexander McMarland, Angelina Petrichenko, John Everett, Frederic Bushman, Teng Fei, Anastasia Kousa, Andri Leo L Lemarquis, Susan DeWolf, Jonathan U. Peled, Santosha A. Vardhana, Christopher A. Klebanoff, Marcel R.M. van den Brink
Journal: Blood (2024)